Biomarcadores emergentes e tecnologias ômicas no manejo da sepse e do choque séptico: do paradigma tradicional à medicina de precisão
Clinics Biopsychosocial · 21.07.2026 · 4 (1) · 40-47
DOI: 10.54727/cbps.4.1.86 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinics Biopsychosocial, online erschienen am 21.07.2026. Verfasst von Júlio Fim Mascarelo und 8 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Sepsis is one of the leading causes of global hospital mortality, requiring early recognition for survival. Traditional biomarkers, such as lactate, C-reactive protein, and procalcitonin, present sensitivity and specificity limitations below 90%, hindering initial diagnosis and risk stratification.
Objective
To evaluate the diagnostic accuracy and prognostic value of several emerging biomarkers and omic technologies in the management of sepsis in adults, contrasting their effectiveness with conventional markers.
Method
Systematic review structured by PRISMA guidelines and the PICO strategy. PubMed/MEDLINE and CAPES Periodicals Portal databases were consulted in April 2026. From the 648 raw records retrieved, 12 original articles were selected after a careful eligibility analysis for qualitative synthesis.
Results
Molecules such as bio-ADM and HBP outperformed lactate in predicting vascular instability and mortality within 30 days. PenKid and the [TIMP-2]·[IGFBP7] index allowed for the early detection of acute kidney injury before creatinine elevation. Presepsin demonstrated high accuracy in detecting bacterial immune activation. Omic technologies and machine learning algorithms reached high AUROCs in the early detection of clinical deterioration. Additionally, markers such as mHLA-DR and sTREM-1 identified PICS syndrome in survivors.
Conclusion
The findings consolidate the transition to precision medicine, definitively overcoming the limited single-biomarker paradigm. The future of management lies in multiplex panels integrated with artificial intelligence clinical decision support systems to reduce global hospital mortality.
Zitieren
APA
Mascarelo, J. F., Carvalho, M. E. F. D., Carvalho, E. D. S., Machado, A. B., Colago, A. C. C., Bissoli, T. S., Moraes, K. E., Pinto, H. P., & Destefani, A. C. (2026). Biomarcadores emergentes e tecnologias ômicas no manejo da sepse e do choque séptico: do paradigma tradicional à medicina de precisão. Clinics Biopsychosocial, 4(1), 40-47. https://doi.org/10.54727/cbps.4.1.86
Vancouver
Mascarelo JF, Carvalho MEFD, Carvalho EDS, Machado AB, Colago ACC, Bissoli TS, et al. Biomarcadores emergentes e tecnologias ômicas no manejo da sepse e do choque séptico: do paradigma tradicional à medicina de precisão. Clinics Biopsychosocial. 2026;4(1):40-47. doi:10.54727/cbps.4.1.86
BibTeX
@article{Mascarelo2026,
author = {Mascarelo, Júlio Fim and Carvalho, Maria Eduarda Ferreira de and Carvalho, Erick Dos Santos and Machado, Alvaro Borlini and Colago, Arnaldo Cezar Covre and Bissoli, Thiago Santos and Moraes, Kian Escalfoni and Pinto, Hudson Pereira and Destefani, Afrânio Côgo},
title = {Biomarcadores emergentes e tecnologias ômicas no manejo da sepse e do choque séptico: do paradigma tradicional à medicina de precisão},
journal = {Clinics Biopsychosocial},
year = {2026},
volume = {4},
number = {1},
pages = {40--47},
doi = {10.54727/cbps.4.1.86}
}
EUVIMED